Paper17319909
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.
Khorana AA and 4 others. J Thromb Haemost, 2007. Cited by 1,327 papers, by iCite.
Cite this record
ConductScience Library. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. Papers, record 17319909. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17319909
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ambulatory Care | Major topic |
| Antineoplastic Agents | Major topic |
| Neoplasms | Major topic |
| Thromboembolism | Major topic |
| Follow-Up Studies | |
| Humans | |
| Mortality | |
| Population Surveillance | |
| Prospective Studies | |
| Time Factors | |
| United States |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 1K23 CA120587 | NCI NIH HHS | United States | K23CA120587 | PubMed and NIH |
Source NIH RePORTER
Trials4
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01853202 | EXercise Training for the Prevention of Cancer Thrombosis (EXPECT) Pilot Trial | Background | ClinicalTrials.gov | |
| NCT04294589 | Evaluation of NETs in Patients With Solid Cancers Associated With a High Risk of Venous Thromboembolic Events | Background | ClinicalTrials.gov | |
| NCT06196918 | Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients | Background | ClinicalTrials.gov | |
| NCT07850453 | Vortosiran for VTE Prevention | Background | ClinicalTrials.gov |
Cited by742
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,327 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42947797 | Knowledge, attitudes, and practices regarding venous thromboembolism prevention in patients with lung cancer. | Front Public Health | 2026 | https://conductscience.org/library/papers/42947797 | PubMed |
| 42912389 | Trends in Direct Oral Anticoagulant Use for Cancer-Associated Venous Thromboembolism. | JAMA Netw Open | 2026 | https://conductscience.org/library/papers/42912389 | PubMed |
| 42898415 | Role of four new blood coagulation tests in cancer stem cell-mediated tumor-related venous thromboembolism. | Bioimpacts | 2026 | https://conductscience.org/library/papers/42898415 | PubMed |
| 42897372 | Ferritin and LDH predict thrombotic risk beyond conventional scoring systems in DLBCL. | Ann Hematol | 2026 | https://conductscience.org/library/papers/42897372 | PubMed |
| 42761046 | Construction and verification of a nomogram to predict the probability of venous thromboembolism in lung cancer patients. | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/42761046 | PubMed |
| 42751713 | Characteristics of Cancer-Associated Thrombosis Based on Changes in Clinically Measurable Coagulation Factors and Coagulation/Fibrinolysis Markers in Patients with Cancer: A Multicenter Cross-Sectional Study. | Ann Vasc Dis | 2026 | https://conductscience.org/library/papers/42751713 | PubMed |
| 42730163 | A Mitochondrial-Related Gene Signature for Diagnosis and Immune Microenvironment Modulation in Lung Cancer and Venous Thromboembolism. | World J Oncol | 2026 | https://conductscience.org/library/papers/42730163 | PubMed |
| 42699731 | Integrating pharmacovigilance and machine learning: bleeding signal detection and risk prediction for oral anticoagulants in cancer patients. | Res Pract Thromb Haemost | 2026 | https://conductscience.org/library/papers/42699731 | PubMed |
| 42653312 | Biomarkers of Hypercoagulability and Thromboinflammation in Cervical Cancer-Associated Thrombosis: A Systematic Review with Translational Insights from Breast Cancer. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653312 | PubMed |
| 42568708 | Temporal validation of the electronic health record cancer-associated thrombosis model in patients with low bleeding risk. | Res Pract Thromb Haemost | 2026 | https://conductscience.org/library/papers/42568708 | PubMed |
| 42566095 | Development and validation of a nomogram for predicting venous thromboembolism risk in colorectal cancer patients undergoing postoperative chemotherapy. | Med Oncol | 2026 | https://conductscience.org/library/papers/42566095 | PubMed |
| 42487960 | Development and validation of an interpretable machine learning model for venous thromboembolism risk prediction in patients with lung cancer: a real-world study. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42487960 | PubMed |
| 42473469 | Venous mechanical thrombectomy for deep vein thrombosis in patients with cancer: a single-center prospective study. | Blood Vessel Thromb Hemost | 2026 | https://conductscience.org/library/papers/42473469 | PubMed |
| 42449662 | Hypercoagulability Predicts Survival and Reflects NET-Associated Thromboinflammation in Advanced Pancreatic Cancer. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42449662 | PubMed |
| 42369044 | Clinical dose of enoxaparin enhances oncolytic virus M1 infection and antitumor efficacy in human bladder cancer. | iScience | 2026 | https://conductscience.org/library/papers/42369044 | PubMed |
| 42368860 | Preoperative cardiovascular evaluation in patients with cancer. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42368860 | PubMed |
| 42319679 | Platelet-Prostate cancer crosstalk driving disparities and therapeutic vulnerabilities. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42319679 | PubMed |
| 42308329 | Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17-driven endothelial activation. | Sci Transl Med | 2026 | https://conductscience.org/library/papers/42308329 | PubMed |
| 42305777 | GLOBE: an explainable machine learning platform for preoperative prediction of thromboembolism and neurological deterioration in patients with glioma. | Front Neurosci | 2026 | https://conductscience.org/library/papers/42305777 | PubMed |
| 42295501 | Safety and Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis: A Systematic Review and Meta-analysis. | Drug Saf | 2026 | https://conductscience.org/library/papers/42295501 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17319909
GET https://conductscience.org/api/papers/v1/17319909/cited_by?page=2